Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Financial Report: Alexion 1Q | Contract Pharma

What are you searching for?

Sign in
Breaking News, Financial News

Financial Report: Alexion 1Q

Soliris sales up 6%

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Alexion

1Q Revenues: $600.3 million (+6%)

1Q Earnings: $91.3 million (-43%)

Comments: Sales of Soliris were $600.3 million, up 6%. The company entered three agreements in 1Q for the clinical development and commercialization of drug products and recorded R&D expense for upfront payments of $112.0 million. Restructuring expenses in the quarter related to the relocation of its European headquarters from Lausanne to Zurich, were $7.1 million.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters